Joyce Tsi Tan is a notable inventor based in Chapel Hill, NC (US). She has made significant contributions to the field of immunotherapy, particularly in the development of vaccine-based treatments for prostate-associated antigens. With a total of 3 patents to her name, her work is paving the way for advancements in cancer treatment.

Latest Patents

Joyce's latest patents focus on prostate-associated antigens and vaccine-based immunotherapy regimens. The present disclosure provides isolated immunogenic PAA polypeptides, isolated nucleic acid molecules encoding these polypeptides, and vaccine compositions that include either an immunogenic PAA polypeptide or an isolated nucleic acid molecule. Additionally, her patents detail methods relating to the uses of these polypeptides, nucleic acid molecules, and compositions. Furthermore, the vaccine-based immunotherapy regimens involve the co-administration of a vaccine in combination with an immune-suppressive-cell inhibitor and an immune-effector-cell enhancer.

Career Highlights

Joyce Tsi Tan is currently employed at Pfizer Corporation, where she continues to innovate and contribute to the field of immunotherapy. Her work is recognized for its potential impact on cancer treatment and patient outcomes.

Collaborations

Some of her notable coworkers include Joseph John Binder and Helen Kim Cho, who collaborate with her on various projects within the company.

Conclusion

Joyce Tsi Tan's contributions to the field of immunotherapy through her patents and work at Pfizer Corporation highlight her as a key figure in the advancement of cancer treatment. Her innovative approaches are set to make a lasting impact on the medical community.

This text is generated by artificial intelligence and may not be accurate.